Zonulin1

Zonulin1

$32.20
RV96

Zonulin1 brings together selected traditional Chinese medicine ingredients with Lactobacillus acidophilus in a practitioner-only formulation.

The formula profile is relevant to practitioners interested in gastrointestinal barrier research, tight junction pathways, inflammatory signalling and ingredient-level professional education.

60 x 500 mg capsules | AUST L 307196

Each 500 mg capsule contains:

Bupleurum falcatum root dry extract 100 mg
Equivalent to dry root 1 g

Citrus aurantium fruit dry extract 100 mg
Equivalent to dry fruit 600 mg
Containing oxedrine 8.8 mg

Paeonia lactiflora root dry extract 125 mg
Equivalent to dry root 750 mg

Glycyrrhiza uralensis root dry extract 50 mg
Equivalent to dry root 300 mg

Lactobacillus acidophilus 100 mg

Traditionally used in Chinese medicine to help relieve inflammation.

Zonulin1 may be considered by qualified healthcare practitioners where a traditional Chinese medicine approach to relieving inflammation is appropriate.

Broader discussion of zonulin, tight junctions, intestinal permeability and ingredient research is provided in the Practitioner Research tab for professional education only.

Directions

For practitioner-directed use only.

Maximum daily dose: 2 capsules daily.

Maximum single dose: 1 capsule.

Dosage and duration should be determined by the treating healthcare practitioner based on individual assessment and must not exceed the ARTG-listed maximum daily dose. The ARTG record lists maximum daily dose as 2 and maximum single dose as 1.

Warnings / precautions

If symptoms persist, talk to your health professional.

Not recommended during pregnancy unless advised by a qualified healthcare practitioner.

This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level and pathway-level research. It does not represent additional ARTG indications for Zonulin1.

Zonulin and gastrointestinal barrier research

Zonulin and tight junction regulation have become important areas of gastrointestinal barrier research. Published literature has explored the role of zonulin in intestinal permeability, epithelial barrier function and immune-related pathways.

This information is provided as scientific background for practitioners and should not be interpreted as a product indication.

Tight junction and inflammatory pathway research

Tight junctions are key structures involved in gastrointestinal barrier function. Published research has explored how epithelial permeability and tight junction integrity may be influenced by inflammatory, immune and oxidative stress pathways.

Zonulin1 contains ingredients associated with traditional herbal constituents including saikosaponins, paeoniflorin, naringin and glycyrrhizic acid, which have been discussed in scientific literature in relation to inflammatory pathways, oxidative stress, epithelial permeability and gastrointestinal barrier research.

Ingredient research highlights

Bupleurum falcatum

Contains saikosaponins, which have been discussed in literature relating to inflammatory signalling pathways, including NF-κB and MAPK-related mechanisms.

Paeonia lactiflora

Contains paeoniflorin, a constituent discussed in literature relating to immune and inflammatory pathway research.

Citrus aurantium

Contains flavonoid constituents such as naringin and naringenin, which have been explored in oxidative stress and inflammatory pathway research.

Glycyrrhiza uralensis

Contains glycyrrhizic acid and related flavonoids, which have been discussed in literature relating to antioxidant and inflammatory pathways.

Lactobacillus acidophilus

Has been explored in gastrointestinal barrier and tight junction research.

The above information is provided to support professional understanding of selected ingredients and biological pathways. It should not be used to promote Zonulin1 for any disease indication not included in the ARTG entry.

References available to registered practitioners on request.